The C-Reactive Protein (CRP) Testing Market is forecasted to reach $6.7 billion by 2034, expanding at a CAGR of 8.80%.
The global C-reactive protein (CRP) testing market was valued at USD 2.9 billion in 2024 and is projected to grow at a CAGR of 8.80% from 2025 to 2034. Market expansion is fueled by increasing incidence of inflammatory diseases and chronic conditions.
Market Trends & Insights:
- Rising Use in Cardiovascular Risk Assessment: CRP testing is increasingly being used alongside other markers to evaluate heart disease risk and monitor therapeutic response.
- Shift Toward Point-of-Care Testing (POCT): Rapid, user-friendly CRP test kits are gaining traction in primary care and home settings for faster diagnosis and patient convenience.
- Integration with Digital Health Tools: CRP tests are being integrated with electronic health records and digital monitoring platforms for real-time data analysis and clinical decision support.
- Increased Screening for Inflammatory Disorders: Demand is rising for CRP testing in the early detection of sepsis, rheumatoid arthritis, and inflammatory bowel diseases.
- Growing Geriatric Population: Age-related diseases that require inflammation monitoring are fueling the need for routine CRP testing.
Market Size & Forecast
Market size value in 2025 USD – 3.16 billion
Revenue forecast in 2034 USD – 6.7 billion
CAGR – 8.80% from 2025 – 2034
Request for Free Sample:
Market Overview:
The C-reactive protein (CRP) testing market is witnessing strong growth due to increasing prevalence of chronic diseases, rising awareness of early disease detection, and the growing need for precise inflammatory marker monitoring. CRP is a key biomarker used in the diagnosis and management of conditions such as cardiovascular diseases, infections, and autoimmune disorders. The market spans clinical laboratories, hospitals, and point-of-care settings, supported by advancements in diagnostic technologies and greater access to healthcare services.
Market Growth Drivers:
- Surge in Chronic and Infectious Diseases: The global rise in cardiovascular diseases, respiratory infections, and autoimmune conditions is significantly boosting CRP test adoption.
- Advancements in Diagnostic Technology: Enhanced test sensitivity, automation, and miniaturized devices are expanding test accuracy and availability across diverse settings.
- Preventive Healthcare Awareness: Increasing awareness about early disease detection and proactive health management is encouraging more routine use of CRP tests.
- Expansion of Healthcare Infrastructure: Improved diagnostic access in developing regions is facilitating broader CRP test utilization in clinical practice.
Market Challenges:
- Limited Specificity of CRP: While C-Reactive Protein Testing indicates inflammation, it is not disease-specific, requiring follow-up tests to identify the underlying cause.
- Cost Constraints in Low-Income Regions: Affordability and availability of high-quality CRP tests remain concerns in some emerging markets.
- Lack of Awareness in Primary Care: In some regions, general practitioners may underutilize CRP testing due to limited familiarity or training.
- Variability in Test Standards: Inconsistencies in test protocols and interpretation across laboratories can impact diagnostic reliability and treatment decisions.
